We are live on ! Find out more
JP Morgan Chase

JP Morgan Chase Portfolio holdings

AUM $1.81T
1-Year Est. Return 41.13%
 

JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.

This Fund
S&P 500
This Quarter Est. Return
-3.76%
1 Year Est. Return
+41.13%
3 Year Est. Return
+122.17%
5 Year Est. Return
+152.24%
10 Year Est. Return
+596.65%
AUM
$696B
AUM Growth
-$21.5B
Cap. Flow
+$1.6B
Cap. Flow %
0.23%
Top 10 Hldgs %
17.34%
Holding
7,216
New
556
Increased
2,573
Reduced
2,583
Closed
516
Avg Time Held Equity + Options
17 quarters
Top 10 Avg Time Held Equity + Options
15.5 quarters
Top 20 Avg Time Held Equity + Options
12.7 quarters
Avg Time Held Equity only
18.5 quarters
Top 10 Avg Time Held Equity only
15.5 quarters
Top 20 Avg Time Held Equity only
14.4 quarters

Sector Composition

Rank Sector Weight
1 Miscellaneous 27.52%
2 Technology 14.62%
3 Healthcare 12.48%
4 Financials 10.51%
5 Consumer Discretionary 8.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
BAH icon
376
Booz Allen Hamilton
BAH
$8.89B
$309M 0.04%
3,342,486
-168,965
-5% -$16M
2013 Q2
37 quarters
BHVN
377
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$309M 0.04%
2,041,718
+1,165,134
+133% +$173M
2017 Q2
21 quarters
RF icon
378
Regions Financial
RF
$23B
$308M 0.04%
15,327,784
-1,066,323
-7% -$22.5M
2013 Q2
37 quarters
BEKE icon
379
KE Holdings
BEKE
$19.6B
$304M 0.04%
17,337,796
+7,631,627
+79% +$124M
2020 Q3
8 quarters
UDR icon
380
UDR
UDR
$11B
$302M 0.04%
7,242,477
-817,452
-10% -$37.5M
2013 Q2
37 quarters
FRT icon
381
Federal Realty Investment Trust
FRT
$9.22B
$302M 0.04%
3,346,584
-301,581
-8% -$30.6M
2013 Q2
37 quarters
MIDD icon
382
Middleby
MIDD
$4.79B
$300M 0.04%
2,339,385
+292,928
+14% +$41.1M
2013 Q2
37 quarters
EIX icon
383
Edison International
EIX
$21.3B
$298M 0.04%
5,264,865
-318,858
-6% -$21.1M
2013 Q2
37 quarters
COO icon
384
Cooper Companies
COO
$10.3B
$293M 0.04%
4,440,092
+140,760
+3% +$10.8M
2013 Q2
37 quarters
NWL icon
385
Newell Brands
NWL
$2.4B
$292M 0.04%
21,056,719
+467,106
+2% +$8.72M
2013 Q2
37 quarters
OTIS icon
386
Otis Worldwide
OTIS
$25.1B
$292M 0.04%
4,574,986
-1,708,085
-27% -$125M
2020 Q2
9 quarters
POST icon
387
Post Holdings
POST
$3.39B
$291M 0.04%
3,557,357
-268,422
-7% -$23.2M
2013 Q2
37 quarters
LSXMK
388
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
$291M 0.04%
9,958,521
-513,169
-5% -$16M
2016 Q2
25 quarters
OEF icon
389
iShares S&P 100 ETF
OEF
$20.8B
$290M 0.04%
1,787,228
+1,085,158
+155% +$197M
2013 Q2
37 quarters
ROST icon
390
Ross Stores
ROST
$71B
$289M 0.04%
3,428,119
+739,873
+28% +$62.8M
2013 Q2
37 quarters
A icon
391
Agilent Technologies
A
$48.1B
$288M 0.04%
2,367,452
+31,038
+1% +$3.99M
2013 Q2
37 quarters
CBRE icon
392
CBRE Group
CBRE
$37.9B
$286M 0.04%
4,235,714
-3,592
-0.1% -$285K
2013 Q2
37 quarters
AAPL icon
393
CALL
Apple
AAPL
$4.91T
$286M 0.04%
2,066,800
-737,800
-26% -$116M
2014 Q3
32 quarters
DUK icon
394
Duke Energy
DUK
$91B
$285M 0.04%
3,063,538
+52,796
+2% +$5.67M
2013 Q2
37 quarters
ESGD icon
395
iShares ESG Aware MSCI EAFE ETF
ESGD
$11.8B
$282M 0.04%
5,023,345
+81,113
+2% +$5.08M
2017 Q4
19 quarters
HES
396
DELISTED
Hess
HES
$282M 0.04%
2,583,110
-208,275
-7% -$23.1M
2013 Q2
37 quarters
VOX icon
397
Vanguard Communication Services ETF
VOX
$5.79B
$281M 0.04%
3,411,696
-482,351
-12% -$46M
2015 Q4
27 quarters
RMD icon
398
ResMed
RMD
$32.4B
$280M 0.04%
1,281,049
+170,480
+15% +$38.8M
2013 Q2
37 quarters
CNP icon
399
CenterPoint Energy
CNP
$25.4B
$278M 0.04%
9,877,924
-675,149
-6% -$21.1M
2013 Q2
37 quarters
AMT icon
400
American Tower
AMT
$84.9B
$276M 0.04%
1,287,471
-142,003
-10% -$36.5M
2013 Q2
37 quarters

Similar funds

JP Morgan Chase's Q3 2022 Portfolio in Review

As of Q3 2022, JP Morgan Chase held 7,216 positions worth $696B, down 3% from $718B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

JP Morgan Chase's Q3 2022 filing shows 556 new, 2,573 increased, 2,583 reduced and 516 closed positions. Its largest new stake was Franklin FTSE Japan ETF: 3,003,780 shares worth $65.1M. The largest sale was JPMorgan BetaBuilders Europe ETF, an estimated $1.25B.

By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, up from 26% a quarter earlier, followed by Technology and Healthcare.

  • JP Morgan Chase's largest Q3 2022 buy was Franklin FTSE Japan ETF: 3,003,780 shares worth $65.1M.
  • JP Morgan Chase added most to Invesco QQQ Trust in Q3 2022, an estimated $1.97B increase.
  • JP Morgan Chase's biggest Q3 2022 reduction was JPMorgan BetaBuilders Europe ETF, cutting an estimated $1.25B.
  • JP Morgan Chase fully exited CMC Materials, Inc. Common Stock in Q3 2022, selling an estimated $248M.
  • JP Morgan Chase's ten largest holdings make up 17% of its $696B portfolio in Q3 2022.
  • JP Morgan Chase opened 556 new positions and closed 516 in Q3 2022.
  • JP Morgan Chase's portfolio value fell 3% quarter-over-quarter to $696B.

Based on JP Morgan Chase's 13F filing for Q3 2022, filed 14 Nov 2022.